Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.040
-0.110 (-3.49%)
At close: Feb 20, 2026, 4:00 PM EST
3.070
+0.030 (0.99%)
After-hours: Feb 20, 2026, 7:48 PM EST
LIXT Market Cap
LIXT has a market cap or net worth of $26.49 million as of February 20, 2026. Its market cap has increased by 372.95% in one year.
Market Cap
26.49M
Enterprise Value
23.60M
1-Year Change
372.95%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $26.49M, a decrease of -44.12%. That is a compound annual growth rate of -10.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 17.30M | -22.77% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 29.74M |
| Rein Therapeutics | 29.44M |
| NeuroSense Therapeutics | 29.40M |
| Dyadic International | 29.15M |
| Evaxion | 29.02M |
| BriaCell Therapeutics | 28.90M |
| Passage Bio | 28.64M |
| Hyperion DeFi | 27.96M |